Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasushi Okoshi

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2002
Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entityHarumi Y Mukai, Yuichi Hasegawa, Hiroshi Kojima, et al.
Oncology Research and Treatment|August 21, 2014
Prognosis factors in Japanese elderly patients with primary central nervous system lymphoma treated with a nonradiation, intermediate-dose methotrexate-containing regimenSuk-Young Lee, Yasushi Okoshi, Naoki Kurita, et al.
European Journal of Haematology|May 21, 2003
Successful treatment of a patient with subcutaneous panniculitis-like T-cell lymphoma with high-dose chemotherapy and total body irradiationHarumi Y Mukai, Yasushi Okoshi, Seiichi Shimizu, et al.
International Immunology|December 1, 2004
Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3Yasushi Okoshi, Satoko Tahara-Hanaoka, Chigusa Nakahashi, et al.
Internal Medicine (Tokyo, Japan)|April 7, 2017
Lymphoplasmacytic Lymphoma Presenting with Diarrhea and Joint Pain Which was Successfully Diagnosed by an MYD88 Mutation AnalysisMasaya Fukushima, Yasushi Okoshi, Keiko Fukazawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
Dual assemblies of an activating immune receptor, MAIR-II, with ITAM-bearing adapters DAP12 and FcRgamma chain on peritoneal macrophagesChigusa Nakahashi, Satoko Tahara-Hanaoka, Naoya Totsuka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 26, 2003
[A long-lasting idiopathic factor V inhibitor]Yasushi Okoshi, Hideki Akiyama, Takashi Inoue, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 2, 2011
A highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphomaNaoki Kurita, Hidekazu Nishikii, Rie Nakamoto, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|November 23, 2011
Treatment outcome of adult Burkitt Lymphoma in Japanese patients with modified LMB protocol : a single center retrospective analysisHidekazu Nishikii, Naoya Nakamura, Yuzuru Kondo, et al.
European Journal of Haematology|January 29, 2008
Detection of the STAT5B-RARA fusion transcript in acute promyelocytic leukemia with the normal chromosome 17 on G-bandingManabu Kusakabe, Kazumi Suzukawa, Toru Nanmoku, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2002
Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entityHarumi Y Mukai, Yuichi Hasegawa, Hiroshi Kojima, et al.
Oncology Research and Treatment|August 21, 2014
Prognosis factors in Japanese elderly patients with primary central nervous system lymphoma treated with a nonradiation, intermediate-dose methotrexate-containing regimenSuk-Young Lee, Yasushi Okoshi, Naoki Kurita, et al.
European Journal of Haematology|May 21, 2003
Successful treatment of a patient with subcutaneous panniculitis-like T-cell lymphoma with high-dose chemotherapy and total body irradiationHarumi Y Mukai, Yasushi Okoshi, Seiichi Shimizu, et al.
International Immunology|December 1, 2004
Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3Yasushi Okoshi, Satoko Tahara-Hanaoka, Chigusa Nakahashi, et al.
Internal Medicine (Tokyo, Japan)|April 7, 2017
Lymphoplasmacytic Lymphoma Presenting with Diarrhea and Joint Pain Which was Successfully Diagnosed by an MYD88 Mutation AnalysisMasaya Fukushima, Yasushi Okoshi, Keiko Fukazawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
Dual assemblies of an activating immune receptor, MAIR-II, with ITAM-bearing adapters DAP12 and FcRgamma chain on peritoneal macrophagesChigusa Nakahashi, Satoko Tahara-Hanaoka, Naoya Totsuka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 26, 2003
[A long-lasting idiopathic factor V inhibitor]Yasushi Okoshi, Hideki Akiyama, Takashi Inoue, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 2, 2011
A highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphomaNaoki Kurita, Hidekazu Nishikii, Rie Nakamoto, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|November 23, 2011
Treatment outcome of adult Burkitt Lymphoma in Japanese patients with modified LMB protocol : a single center retrospective analysisHidekazu Nishikii, Naoya Nakamura, Yuzuru Kondo, et al.
European Journal of Haematology|January 29, 2008
Detection of the STAT5B-RARA fusion transcript in acute promyelocytic leukemia with the normal chromosome 17 on G-bandingManabu Kusakabe, Kazumi Suzukawa, Toru Nanmoku, et al.
Pageof 4